Oxford Asset Management »

Maze Therapeatics shares owned by Oxford Asset Management

Quarter-by-quarter ownership of Maze Therapeatics (MAZE) shares owned by Oxford Asset Management from 13F filings

Historical chart of Oxford Asset Management investment in Maze Therapeatics

Tip: Access up to 7 years of quarterly data

All positions including Maze Therapeatics held by Oxford Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maze Therapeatics by Oxford Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $187k 17k 11.01

More positions owned by Oxford Asset Management

Spdr Series Trust S&p Biotech (XBI)
Snap Note 0.125% 3/0
Freeport-mcmoran CL B (FCX)
Dropbox Note 3/0
General Mills (GIS)
Ford Motor Company (F)
Comcast Corp Cl A (CMCSA)
Citigroup Com New (C)
Ferguson Enterprises Common Stock New (FERG)
Nike CL B (NKE)
Amazon (AMZN)
Boeing Company (BA)
EOG Resources (EOG)
Pfizer (PFE)
Meridianlink Common Stock (MLNK)

View all positions for Oxford Asset Management

Top funds holding Maze Therapeatics

Trv Gp Iv
Frazier Life Sciences Management
Arch Venture Corp
Deep Track Capital
Alphabet
AH Capital Management
Matrix Capital Management Company
Vanguard Group
BlackRock
VR Adviser
Logos Global Management
General Catalyst Group Management
Woodline Partners
TRV GP V
Marshall Wace

View all funds holding Maze Therapeatics